BIO Middle East (BIOME)

Program overview

Taking place alongside CPHI Middle East 2026, BIO Middle East serves as a specialized biotechnology platform that complements the region’s largest pharmaceutical gathering. While CPHI brings together the full pharmaceutical value chain, BIO Middle East focuses on advanced biotechnology, strategic partnerships, and life sciences innovation. As the region’s pioneering platform for strategic networking and high-impact public-private collaboration, the event connects global and regional leaders through the partneringONE platform, enabling curated meetings that foster partnerships, licensing opportunities, and investment deals. Co-located with CPHI Middle East, BIO Middle East features a focused agenda covering cell and gene therapies, mRNA technologies, next-generation vaccines, and biomanufacturing — offering a unique blend of scientific insight and commercial opportunity that drives biotech growth across Saudi Arabia and the wider region. Register Now Together, the two events create a comprehensive industry ecosystem — uniting pharma manufacturing, biotech innovation, investment, and research — and reinforcing Saudi Arabia’s growing role as a regional and global hub for healthcare and life sciences.